J.HaakH
Adding to our concerns about potential abuse and overuse of the new GLP-1RA medications is the increasing medicalization of pediatric conditions [Reference Marty, Alvey, Mann and Murphy17], many of which result from environmental and societal rather than biological mechanisms, and the lack of progress in particular made in addressing the environmental and lifestyle issues that have contributed immeasurably to the childhood obesity epidemic
Now Markert, who switched to Blue Cross this year, will pay $500 a month out of pocket, the equivalent of a car payment
The critical conversation that isn't always happening: fat loss versus muscle loss One of the most important, and most neglected, conversations around GLP-1 drugs is the distinction between fat loss and total weight loss
When available, COA or batch documentation should be referenced for identity and quality review before use in any research workflow
Our study synthesized evidence based on 15 clinical trials of ALC for depressive disorders